211 related articles for article (PubMed ID: 9648247)
81. Alpha 1----3-galactosyltransferase: the use of recombinant enzyme for the synthesis of alpha-galactosylated glycoconjugates.
Joziasse DH; Shaper NL; Salyer LS; Van den Eijnden DH; van der Spoel AC; Shaper JH
Eur J Biochem; 1990 Jul; 191(1):75-83. PubMed ID: 2116309
[TBL] [Abstract][Full Text] [Related]
82. Heterobifunctional ligands: practical chemoenzymatic synthesis of a cell adhesive glycopeptide that interacts with both selectins and integrins.
Matsuda M; Nishimura S; Nakajima F; Nishimura T
J Med Chem; 2001 Mar; 44(5):715-24. PubMed ID: 11262082
[TBL] [Abstract][Full Text] [Related]
83. Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology.
Thomas LJ; Panneerselvam K; Beattie DT; Picard MD; Xu B; Rittershaus CW; Marsh HC; Hammond RA; Qian J; Stevenson T; Zopf D; Bayer RJ
Glycobiology; 2004 Oct; 14(10):883-93. PubMed ID: 15190008
[TBL] [Abstract][Full Text] [Related]
84. Poly-N-acetyllactosaminyl O-glycans attached to leukosialin. The presence of sialyl Le(x) structures in O-glycans.
Maemura K; Fukuda M
J Biol Chem; 1992 Dec; 267(34):24379-86. PubMed ID: 1447188
[TBL] [Abstract][Full Text] [Related]
85. Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia alpha 2,3Gal, respectively.
Smith PL; Bousfield GR; Kumar S; Fiete D; Baenziger JU
J Biol Chem; 1993 Jan; 268(2):795-802. PubMed ID: 8419356
[TBL] [Abstract][Full Text] [Related]
86. Purification of the beta-N-acetylglucosaminide alpha 1----3-fucosyltransferase from human serum.
Sarnesto A; Köhlin T; Hindsgaul O; Vogele K; Blaszczyk-Thurin M; Thurin J
J Biol Chem; 1992 Feb; 267(4):2745-52. PubMed ID: 1733970
[TBL] [Abstract][Full Text] [Related]
87. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys.
Brown JR; Fuster MM; Whisenant T; Esko JD
J Biol Chem; 2003 Jun; 278(26):23352-9. PubMed ID: 12686549
[TBL] [Abstract][Full Text] [Related]
88. Chemoenzymatic synthesis of dendritic sialyl Lewis(x).
Palcic MM; Li H; Zanini D; Bhella RS; Roy R
Carbohydr Res; 1997 Dec; 305(3-4):433-42. PubMed ID: 9648262
[TBL] [Abstract][Full Text] [Related]
89. Glycolipid acceptor specificity of a human Gal beta(1-3/1-4) GlcNAc alpha 2,3-sialyltransferase.
Miyamoto D; Takashima S; Suzuki T; Nishi T; Sasaki K; Morishita Y; Suzuki Y
Biochem Biophys Res Commun; 1995 Dec; 217(3):852-8. PubMed ID: 8554608
[TBL] [Abstract][Full Text] [Related]
90. Synergistic interactions of the two classes of ligand, sialyl-Lewis(a/x) fuco-oligosaccharides and short sulpho-motifs, with the P- and L-selectins: implications for therapeutic inhibitor designs.
Galustian C; Childs RA; Stoll M; Ishida H; Kiso M; Feizi T
Immunology; 2002 Mar; 105(3):350-9. PubMed ID: 11918697
[TBL] [Abstract][Full Text] [Related]
91. Sulfated blood group Lewis(a). A superior oligosaccharide ligand for human E-selectin.
Yuen CT; Bezouska K; O'Brien J; Stoll M; Lemoine R; Lubineau A; Kiso M; Hasegawa A; Bockovich NJ; Nicolaou KC
J Biol Chem; 1994 Jan; 269(3):1595-8. PubMed ID: 7507478
[TBL] [Abstract][Full Text] [Related]
92. Regulation of chondroitin sulfate biosynthesis by specific sulfation: acceptor specificity of serum beta-GalNAc transferase revealed by structurally defined oligosaccharides.
Kitagawa H; Tsutsumi K; Ujikawa M; Goto F; Tamura J; Neumann KW; Ogawa T; Sugahara K
Glycobiology; 1997 Jun; 7(4):531-7. PubMed ID: 9184834
[TBL] [Abstract][Full Text] [Related]
93. The asparagine-linked oligosaccharides on tissue factor pathway inhibitor terminate with SO4-4GalNAc beta 1, 4GlcNAc beta 1,2 Mana alpha.
Smith PL; Skelton TP; Fiete D; Dharmesh SM; Beranek MC; MacPhail L; Broze GJ; Baenziger JU
J Biol Chem; 1992 Sep; 267(27):19140-6. PubMed ID: 1388166
[TBL] [Abstract][Full Text] [Related]
94. Utilization of glycosyltransferases to change oligosaccharide structures.
Guo Z; Wang PG
Appl Biochem Biotechnol; 1997; 68(1-2):1-20. PubMed ID: 9373927
[TBL] [Abstract][Full Text] [Related]
95. Systematic synthesis of N-methyl-1-deoxynojirimycin-containing, Le(x), Le(a), sialyl-Le(x) and sialyl-Le(a) epitopes recognized by selectins.
Kiso M; Furui H; Ando K; Ishida H; Hasegawa A
Bioorg Med Chem; 1994 Nov; 2(11):1295-308. PubMed ID: 7538870
[TBL] [Abstract][Full Text] [Related]
96. Molecular cloning of a human fucosyltransferase gene that determines expression of the Lewis x and VIM-2 epitopes but not ELAM-1-dependent cell adhesion.
Lowe JB; Kukowska-Latallo JF; Nair RP; Larsen RD; Marks RM; Macher BA; Kelly RJ; Ernst LK
J Biol Chem; 1991 Sep; 266(26):17467-77. PubMed ID: 1716630
[TBL] [Abstract][Full Text] [Related]
97. Use of the "core-2"-N-acetylglucosaminyltransferase in the chemical-enzymatic synthesis of a sialyl-LeX-containing hexasaccharide found on O-linked glycoproteins.
Oehrlein R; Hindsgaul O; Palcic MM
Carbohydr Res; 1993 May; 244(1):149-59. PubMed ID: 8101768
[TBL] [Abstract][Full Text] [Related]
98. Human liver and human placenta both contain CMP-NeuAc:Gal beta 1-->4GlcNAc-R alpha 2-->3- as well as alpha 2-->6-sialyltransferase activity.
Nemansky M; Schiphorst WE; Koeleman CA; Van den Eijnden DH
FEBS Lett; 1992 Nov; 312(1):31-6. PubMed ID: 1426235
[TBL] [Abstract][Full Text] [Related]
99. Chemical synthesis of sulfated oligosaccharides with a beta-D-Gal-(1-->3).
Xia J; Srikrishnan T; Alderfer JL; Jain RK; Piskorz CF; Matta KL
Carbohydr Res; 2000 Nov; 329(3):561-77. PubMed ID: 11128585
[TBL] [Abstract][Full Text] [Related]
100. Use of human-milk fucosyltransferase in the chemoenzymic synthesis of analogues of the sialyl Lewis(a) and sialyl Lewis(x) tetrasaccharides modified at the C-2 position of the reducing unit.
Nikrad PV; Kashem MA; Wlasichuk KB; Alton G; Venot AP
Carbohydr Res; 1993 Dec; 250(1):145-60. PubMed ID: 8143288
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
